Results 61 to 70 of about 6,300 (191)

Tirofiban for Cocaine-Induced Coronary Artery Thrombosis [PDF]

, 1999
Nikolaos G. Frangogiannis, John A. Farmer, Nasser Lakkis   +2 more
openalex   +1 more source

Tirofiban-Induced Thrombocytopenia Occurring with Crohn’s Disease

Case Reports in Cardiology, 2016
A 69-year-old man, with severe refractory Crohn’s disease, presented with acute coronary syndrome that required angioplasty. He developed severe tirofiban-induced thrombocytopenia (TIT) heralded by type I allergic reaction that required steroids and a combination of antihistamine H1 and antihistamine H2 for symptomatic management.
Fady El Karak, Assem Araji, Elie El Rassy, Toni Ibrahim   +3 more
openaire   +3 more sources

Gene mutations of platelet glycoproteins and response to tirofiban in acute coronary syndrome

São Paulo Medical Journal
CONTEXT AND OBJECTIVES: Glycoprotein inhibitors (abciximab, eptifibatide and tirofiban) are used in patients with unstable angina and non-ST-segment elevation myocardial infarction before percutaneous coronary intervention.
Antonio de Padua Mansur, Alessandra Roggerio, Júlio Yoshio Takada, Pérola Michelle Vasconcelos Caribé, Solange Desirée Avakian, Célia Maria Cassaro Strunz   +5 more
doaj   +1 more source

Cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia II and impaired renal function using heparin and the platelet GP IIb/IIIa inhibitor tirofiban as anticoagulant [PDF]

, 2000
Andreas Koster, Matthias Loebe, F. Mertzlufft, Hermann Kuppe, R. Hetzer   +4 more
openalex   +1 more source

TARGET: Do Tirofiban And ReoPro Give Similar Efficacy Trial? [PDF]

, 2000
Eric J. Topol
openalex   +1 more source

Desenlaces clínicos en una cohorte de pacientes con síndrome coronario agudo y administración intracoronaria de tirofiban

Revista Colombiana de Cardiología, 2015
Introducción: Los inhibidores de glicoproteína IIb/IIIa reducen los eventos cardiovasculares mayores adversos (MACE) en pacientes con síndrome coronario agudo.
Julián Ochoa, Jorge G. Velásquez, Jorge A. Cedano, Camila Ospina, Lina Merchancano, Diana C. Carrillo   +5 more
doaj   +1 more source

Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban [PDF]

, 2001
Christopher P. Cannon, William S. Weintraub, Laura A. Demopoulos, Ralph Vicari, Martin J. Frey, Nasser Lakkis, Franz‐Josef Neumann, Debbie Robertson, Paul DeLucca, Peter M. DiBattiste, C. Michael Gibson, Eugene Braunwald   +11 more
openalex   +1 more source

Comparison of Two Platelet Glycoprotein IIb/IIIa Inhibitors, Tirofiban and Abciximab, for the Prevention of Ischemic Events with Percutaneous Coronary Revascularization [PDF]

, 2001
Eric J. Topol, David J. Moliterno, Howard C. Herrmann, Eric R. Powers, Cindy L. Grines, David J. Cohen, Eric A. Cohen, Michel E. Bertrand, Franz‐Josef Neumann, Gregg W. Stone, Peter M. DiBattiste, Steven J. Yakubov, Paul DeLucca, Laura A. Demopoulos   +13 more
openalex   +1 more source

There is no difference in safety and efficacy mechanical thrombectomy alone or mechanical thrombectomy with tirofiban for patients undergoing treatment of large vessel occlusion and underlying intracranial atherosclerosis

Interdisciplinary Neurosurgery, 2022
Background: Mechanical thrombectomy (MT) is a widely proven method to treat acute ischemic stroke (AIS) during mechanical thrombectomy and acute stenting and angioplasty is a topic discussed till this day regarding safety and efficacy.
Hari Movva, Rani Rabah, Wondwossen Tekle, Laurie Preston, Hari Kotta, Ameer E Hassan   +5 more
doaj  

Anticoagulation during Cardiopulmonary Bypass in Patients with Heparin-induced Thrombocytopenia Type II and Renal Impairment Using Heparin and the Platelet Glycoprotein IIb–IIIa Antagonist Tirofiban [PDF]

, 2001
Andreas Koster, Marian Kukucka, Friedhelm Bach, Oliver Meyer, Thomas Fischer, F. Mertzlufft, Matthias Loebe, Roland Hetzer, Hermann Kuppe   +8 more
openalex   +1 more source